Peter Fitzgerald

750 total citations
38 papers, 387 citations indexed

About

Peter Fitzgerald is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Peter Fitzgerald has authored 38 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 8 papers in Immunology. Recurrent topics in Peter Fitzgerald's work include Angiogenesis and VEGF in Cancer (7 papers), Lipid metabolism and disorders (4 papers) and Cell Adhesion Molecules Research (4 papers). Peter Fitzgerald is often cited by papers focused on Angiogenesis and VEGF in Cancer (7 papers), Lipid metabolism and disorders (4 papers) and Cell Adhesion Molecules Research (4 papers). Peter Fitzgerald collaborates with scholars based in France, United Kingdom and Luxembourg. Peter Fitzgerald's co-authors include John Lamont, Sophie Visvikis‐Siest, Hind Berrahmoune, Bernard Herbeth, Maria G. Stathopoulou, Christine Masson, Ndeye Coumba Ndiaye, Mary Jo Kurth, Mohsen Azimi–Nezhad and Mark W. Ruddock and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Peter Fitzgerald

36 papers receiving 381 citations

Peers

Countries citing papers authored by Peter Fitzgerald

Since Specialization

Citations

This map shows the geographic impact of Peter Fitzgerald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Fitzgerald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Fitzgerald more than expected).

Fields of papers citing papers by Peter Fitzgerald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Fitzgerald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Fitzgerald. The network helps show where Peter Fitzgerald may publish in the future.

Co-authorship network of co-authors of Peter Fitzgerald

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Fitzgerald. A scholar is included among the top collaborators of Peter Fitzgerald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Fitzgerald. Peter Fitzgerald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Importance of Diagnostics in the Treatment of Urinary Tract Infections in the United Kingdom 2024 ·Research and Reports in Urology ·Allister Irvine, (unknown), Mary Jo Kurth, John Lamont, Peter Fitzgerald, Mark W. Ruddock	0
2	Design and selection of anti-PD-L1 single-domain antibody and tumor necrosis factor superfamily ligands for an optimal vectorization in an oncolytic virus 2023 ·Frontiers in Bioengineering and Biotechnology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Laetitia Fend, (unknown), Michel Geist, (unknown), (unknown), Nathalie Silvestre, (unknown), Peter Fitzgerald, Éric Quéméneur, Jean‐Baptiste Marchand	1
3	A novel algorithm for cardiovascular screening using conjunctival microcirculatory parameters and blood biomarkers 2022 ·Scientific Reports ·(unknown), (unknown), M. Andrew Nesbit, Mark W. Ruddock, Paul Brennan, (unknown), (unknown), (unknown), Dewar Finlay, Emanuele Trucco, Mary Jo Kurth, (unknown), John Lamont, Peter Fitzgerald, Mark S. Spence, James McLaughlin, Tara Moore	8
4	Biomarkers to assess the risk of bladder cancer in patients presenting with haematuria are gender-specific 2022 ·Frontiers in Oncology ·Brian Duggan, Declan O’Rourke, Neil Anderson, (unknown), (unknown), (unknown), (unknown), David J. Curry, Mark D. Evans, Michael Stevenson, Mary Jo Kurth, John Lamont, Peter Fitzgerald, Mark W. Ruddock	4
5	Biomarkers for Detecting Kidney Dysfunction in Type-2 Diabetics and Diabetic Nephropathy Subjects: A Case-Control Study to Identify Potential Biomarkers of DN to Stratify Risk of Progression in T2D Patients 2022 ·Frontiers in Endocrinology ·(unknown), Diego Cobice, Simon Brockbank, (unknown), (unknown), (unknown), (unknown), Mary Jo Kurth, John Lamont, Peter Fitzgerald, Tara Moore, Mark W. Ruddock	6
6	Blood and urinary cytokine balance and renal outcomes at cardiac surgery 2021 ·BMC Nephrology ·William T. McBride, Mary Jo Kurth, (unknown), (unknown), (unknown), (unknown), John Lamont, Peter Fitzgerald, Mark W. Ruddock	4
7	Epigenome-wide association study detects a novel loci associated with central obesity in healthy subjects 2021 ·BMC Medical Genomics ·Ting Xie, (unknown), Maria G. Stathopoulou, Sébastien Dadé, Eirini Marouli, Christine Masson, (unknown), John Lamont, Peter Fitzgerald, Panos Deloukas, Sophie Visvikis‐Siest	6
8	Epigenome-wide association study in healthy individuals identifies significant associations with DNA methylation and PBMC extract VEGF-A concentration 2020 ·Clinical Epigenetics ·(unknown), (unknown), Sébastien Dadé, Maria G. Stathopoulou, (unknown), Ting Xie, (unknown), Christine Masson, John Lamont, Peter Fitzgerald, Sophie Visvikis‐Siest	7
9	Acute kidney injury risk in orthopaedic trauma patients pre and post surgery using a biomarker algorithm and clinical risk score 2020 ·Scientific Reports ·Mary Jo Kurth, William T. McBride, (unknown), (unknown), (unknown), John Lamont, (unknown), Peter Fitzgerald, Mark W. Ruddock	13
10	Stratifying risk of acute kidney injury in pre and post cardiac surgery patients using a novel biomarker-based algorithm and clinical risk score 2019 ·Scientific Reports ·William T. McBride, Mary Jo Kurth, (unknown), (unknown), John Lamont, (unknown), (unknown), Peter Fitzgerald, Ian Young, (unknown), Mark W. Ruddock	22
11	Peripheral blood mononuclear cells extracts VEGF protein levels and VEGF mRNA: Associations with inflammatory molecules in a healthy population 2019 ·PLoS ONE ·(unknown), (unknown), (unknown), Maria G. Stathopoulou, Sébastien Dadé, Saïd El Shamieh, (unknown), Christine Masson, John Lamont, Peter Fitzgerald, Sophie Visvikis‐Siest	6
12	The Relationship Between Vascular Endothelial Growth Factor Cis- and Trans-Acting Genetic Variants and Metabolic Syndrome 2018 ·The American Journal of the Medical Sciences ·Mohsen Azimi–Nezhad, Seyed Reza Mirhafez, Maria G. Stathopoulou, (unknown), Ndeye Coumba Ndiaye, (unknown), (unknown), Amir Avan, Amélie Bonnefond, (unknown), Hassan Mehrad‐Majd, Bernard Herbeth, John Lamont, Peter Fitzgerald, Gordon A. Ferns, Sophie Visvikis‐Siest, Majid Ghayour‐Mobarhan	7
13	Genetic diagnosis of familial hypercholesterolaemia using a rapid biochip array assay for 40 common LDLR, APOB and PCSK9 mutations 2016 ·Atherosclerosis ·(unknown), (unknown), Pádraig Hart, (unknown), (unknown), (unknown), John Lamont, Peter Fitzgerald, Colin A. Graham	6
14	Angiogenesis related genes NOS3, CD14, MMP3 and IL4R are associated to VEGF gene expression and circulating levels in healthy adults 2015 ·BMC Medical Genetics ·(unknown), Maria G. Stathopoulou, Sébastien Dadé, Ndeye Coumba Ndiaye, Mohsen Azimi–Nezhad, (unknown), Christine Masson, John Lamont, Peter Fitzgerald, Sophie Visvikis‐Siest	29
15	A common variant highly associated with plasma VEGFA levels also contributes to the variation of both LDL-C and HDL-C 2012 ·Journal of Lipid Research ·Maria G. Stathopoulou, Amélie Bonnefond, Ndeye Coumba Ndiaye, Mohsen Azimi–Nezhad, Saïd El Shamieh, (unknown), (unknown), Gérard Siest, John Lamont, Peter Fitzgerald, Sophie Visvikis‐Siest	29
16	Associations of vascular endothelial growth factor (VEGF) with adhesion and inflammation molecules in a healthy population 2012 ·Cytokine ·Mohsen Azimi–Nezhad, Maria G. Stathopoulou, Amélie Bonnefond, (unknown), (unknown), John Lamont, Peter Fitzgerald, Ndeye Coumba Ndiaye, Sophie Visvikis‐Siest	28
17	Functional Epistatic Interaction between rs6046G>A in F7 and rs5355C>T in SELE Modifies Systolic Blood Pressure Levels 2012 ·PLoS ONE ·Saïd El Shamieh, Ndeye Coumba Ndiaye, Maria G. Stathopoulou, (unknown), Christine Masson, John Lamont, Peter Fitzgerald, Athanase Bénétos, Sophie Visvikis‐Siest	7
18	Association between EGF and lipid concentrations: A benefit role in the atherosclerotic process? 2009 ·Clinica Chimica Acta ·Hind Berrahmoune, John Lamont, Bernard Herbeth, Daniel Lambert, Christine Masson, Maria G. McPhillips, Peter Fitzgerald, Sophie Visvikis‐Siest	9
19	Association of classical and related inflammatory markers with high-sensitivity C-reactive protein in healthy individuals: results from the Stanislas cohort 2007 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Hind Berrahmoune, Bernard Herbeth, John Lamont, Daniel Lambert, Stefan Blankenberg, Laurence Tiret, Peter Fitzgerald, Gérard Siest, Sophie Visvikis‐Siest	10
20	Heritability for Plasma VEGF Concentration in the Stanislas Family Study 2006 ·Annals of Human Genetics ·Hind Berrahmoune, Bernard Herbeth, John Lamont, Christine Masson, Peter Fitzgerald, Sophie Visvikis‐Siest	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact